<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03458273</url>
  </required_header>
  <id_info>
    <org_study_id>MW-MULublin-2</org_study_id>
    <nct_id>NCT03458273</nct_id>
  </id_info>
  <brief_title>Real Zero Fluoroscopy Catheter Ablation.</brief_title>
  <acronym>ZERO-Fluoro</acronym>
  <official_title>Multi-center, Observational, Retrospective Comparison of the Feasibility, Safety, and Efficacy of Real Zero Fluoroscopy Versus Conventional Fluoroscopic Catheter Ablation With and Without 3D System Support: Propensity Matched Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Lublin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Lublin</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Retrospective Propensity Matched Study comparing:

        -  real zero fluoroscopy catheter ablation

        -  conventional fluoroscopy catheter ablation without 3D system

        -  conventional fluoroscopy catheter ablation with 3D system
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Catheter ablation is a well-established treatment to treat patients with a wide scope of
      heart arrhythmias.

      The study is an investigator-initiated, retrospective analysis of prospectively collected
      data. The study population consists of patients with right-sided arrhythmias who underwent
      zero-fluoroscopy catheter ablation between the years 2016 and 2018 in 3 centers and a
      propensity score matched patients group of patients who:

        -  underwent conventional fluoroscopy guided catheter ablation without 3D system
           (Ensite/Carto) support

        -  underwent conventional fluoroscopy guided catheter ablation with 3D system
           (Ensite/Carto) support

      Covariates for matching will be:

        -  arrhythmia type

        -  age of a patient

        -  number of diagnostic catheters used during a procedure

        -  type of a diagnostic catheter used during a procedure]
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 10, 2018</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Procedural success rates</measure>
    <time_frame>3 months</time_frame>
    <description>arrhythmia recurrence within 3 months since the index procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total procedure time</measure>
    <time_frame>during procedure</time_frame>
    <description>total procedure time measured as needle to needle time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluoroscopy time</measure>
    <time_frame>during procedure</time_frame>
    <description>total fluoroscopy time during procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute procedural success</measure>
    <time_frame>10-30 minutes</time_frame>
    <description>acute procedural success defined as arhhythia elimination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence rate</measure>
    <time_frame>6 months</time_frame>
    <description>arrhythmia recurrence within 6 months since the index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute Complications rate</measure>
    <time_frame>during procedure</time_frame>
    <description>Procedural Complications procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All Complications rate</measure>
    <time_frame>6 months</time_frame>
    <description>Procedural Complications and Complications within 6 months since the index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The length of stay during the hospitalization</measure>
    <time_frame>1 month</time_frame>
    <description>Number of hospital days for ablation procedure from admission to discharge</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Atrial Arrhythmia</condition>
  <condition>Ventricular Arrythmia</condition>
  <condition>Arrhythmia</condition>
  <condition>Arrhythmias, Cardiac</condition>
  <arm_group>
    <arm_group_label>Zero fluoro</arm_group_label>
    <description>Patients in whom Zero fluoroscopy ablation was performed under the guidance of Ensite for mapping and ablation and fluoroscopy will not be used during the procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional ablation without 3D</arm_group_label>
    <description>Patients in whom Conventional fluoroscopy ablation was performed under fluoroscopic guidance only.
Additional use of Ensite/Carto/Localisa for mapping was not allowed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional ablation with 3D</arm_group_label>
    <description>Patients in whom Conventional fluoroscopy ablation was performed under fluoroscopic and Ensite/Carto guidance and ablation during the procedure.
Use of fluoroscopy and additional Ensite/Carto for mapping and ablation was mandatory.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Zero fluoroscopy ablation</intervention_name>
    <description>Catheter ablation for the treatment of atrial and ventricular arrhythmia - no fluoroscopy guidance</description>
    <arm_group_label>Zero fluoro</arm_group_label>
    <other_name>Zero fluoro</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional ablation without 3D</intervention_name>
    <description>Catheter ablation for the treatment of atrial and ventricular arrhythmia - fluoroscopy guidance only. 3D system (Every Ensite/Carto) is not allowed</description>
    <arm_group_label>Conventional ablation without 3D</arm_group_label>
    <other_name>Conventional fluoroscopy ablation without 3D</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional ablation with 3D</intervention_name>
    <description>Catheter ablation for the treatment of atrial and ventricular arrhythmia - fluoroscopy guidance + 3D system support (Ensite/Carto)</description>
    <arm_group_label>Conventional ablation with 3D</arm_group_label>
    <other_name>Conventional fluoroscopy ablation with 3D</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Zero fluoroscopy group: patients after right atrium/ventricle arrhythmia ablation performed
        with 3D (Ensite/Carto) guidance but without fluoroscopy guidance

        Convectional fluoroscopy group: patients after right atrium/ventricle arrhythmia ablation
        performed with fluoroscopy guidance but without 3D (Ensite/Carto) guidance

        Convectional fluoroscopy group + 3D: patients after right atrium/ventricle arrhythmia
        ablation performed with fluoroscopy guidance and with 3D (Ensite/Carto) guidance
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  right atrial tachycardia

          -  right atrial premature complexes

          -  AVNRT

          -  right atrial AVRT/WPW

          -  right ventricle tachycardia / right ventricle premature complexes

        Exclusion Criteria:

          -  left atrium arrhythmia

          -  left ventricle arrhythmia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Maciej Wójcik, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Lublin, Poland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maciej Wójcik, MD, PhD</last_name>
    <phone>+48817244151</phone>
    <email>m.wojcik@umlub.pl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Wojewódzki Szpital Specjalistyczn</name>
      <address>
        <city>Biała Podlaska</city>
        <zip>21-500</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maciej Wójcik, MD,PhD</last_name>
      <phone>+48817244151</phone>
      <email>m.wojcik@umlub.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of Lublin</name>
      <address>
        <city>Lublin</city>
        <zip>20-091</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maciej Wójcik, MD, PhD</last_name>
      <phone>+48817244151</phone>
      <email>m.wojcik@umlub.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>SP ZOZ Szpital Puławy</name>
      <address>
        <city>Puławy</city>
        <zip>24-100</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maciej Wójcik, MD, PhD</last_name>
      <phone>+48817244151</phone>
      <email>m.wojcik@umlub.pl</email>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <reference>
    <citation>Yang L, Sun G, Chen X, Chen G, Yang S, Guo P, Wang Y, Wang DW. Meta-Analysis of Zero or Near-Zero Fluoroscopy Use During Ablation of Cardiac Arrhythmias. Am J Cardiol. 2016 Nov 15;118(10):1511-1518. doi: 10.1016/j.amjcard.2016.08.014. Epub 2016 Aug 24. Review.</citation>
    <PMID>27639689</PMID>
  </reference>
  <reference>
    <citation>Casella M, Ribatti V, Catto V, Vettor G, Fassini G, Biagioli V, Dello Russo A, Tondo C. Benefits of electroanatomic ablation of conventional cardiac arrhytmias: from fluoroscopy to zero X-ray mapping. Minerva Cardioangiol. 2018 Feb;66(1):49-62. doi: 10.23736/S0026-4725.17.04478-4. Epub 2017 Aug 31.</citation>
    <PMID>28862408</PMID>
  </reference>
  <reference>
    <citation>Gaita F, Guerra PG, Battaglia A, Anselmino M. The dream of near-zero X-rays ablation comes true. Eur Heart J. 2016 Sep 21;37(36):2749-2755. Epub 2016 Jun 26. Review.</citation>
    <PMID>27354053</PMID>
  </reference>
  <reference>
    <citation>Seizer P, Bucher V, Frische C, Heinzmann D, Gramlich M, Müller I, Henning A, Hofbeck M, Kerst G, Gawaz M, Schreieck J. Efficacy and safety of zero-fluoroscopy ablation for supraventricular tachycardias. Use of optional contact force measurement for zero-fluoroscopy ablation in a clinical routine setting. Herz. 2016 May;41(3):241-5. doi: 10.1007/s00059-015-4358-4. Epub 2015 Oct 13.</citation>
    <PMID>26462477</PMID>
  </reference>
  <reference>
    <citation>Bulava A, Hanis J, Eisenberger M. Catheter Ablation of Atrial Fibrillation Using Zero-Fluoroscopy Technique: A Randomized Trial. Pacing Clin Electrophysiol. 2015 Jul;38(7):797-806. doi: 10.1111/pace.12634. Epub 2015 Apr 16.</citation>
    <PMID>25790320</PMID>
  </reference>
  <reference>
    <citation>Scaglione M, Ebrille E, Clemente FD, Gaita F, Bradfield JS. Catheter Ablation of Atrial Fibrillation Without Radiation Exposure Using A 3D Mapping System. J Atr Fibrillation. 2015 Feb 28;7(5):1167. doi: 10.4022/jafib.1167. eCollection 2015 Feb-Mar. Review.</citation>
    <PMID>27957146</PMID>
  </reference>
  <results_reference>
    <citation>Álvarez M, Bertomeu-González V, Arcocha MF, Moriña P, Tercedor L, Ferrero de Loma Á, Pachón M, García A, Pardo M, Datino T, Alonso C, Osca J; investigators of the Spanish Multicenter Registry of Fluoroscopy-free Ablation. Nonfluoroscopic Catheter Ablation. Results From a Prospective Multicenter Registry. Rev Esp Cardiol (Engl Ed). 2017 Sep;70(9):699-705. doi: 10.1016/j.rec.2016.12.040. Epub 2017 Jan 31. English, Spanish.</citation>
    <PMID>28159569</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2018</study_first_submitted>
  <study_first_submitted_qc>March 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2018</study_first_posted>
  <last_update_submitted>March 1, 2018</last_update_submitted>
  <last_update_submitted_qc>March 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Lublin</investigator_affiliation>
    <investigator_full_name>Maciej Wójcik, MD, PhD</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Atrial Arrhythmia</keyword>
  <keyword>Ventricular Arrythmia</keyword>
  <keyword>ablation</keyword>
  <keyword>fluoroscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

